Japan-based Shimadzu Corporation has announced the release of the GCMS-TQ8040 RX and GCMS-TQ8050 RX gas chromatogra...
Takeda China has announced that the National Medical Products Administration (NMPA) has approved the use of ORZEYFUL (ov...
GCCL, a South Korea-based leading provider of clinical trial sample analysis, and China & US based GemPharmatech, a ...
Gerresheimer, an innovative system and solution provider and global partner to the pharma, biotech, and cosmetic industr...
M42’s National Reference Laboratory (NRL), a leading provider of diagnostic services in the region, has entered in...
Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies for rare and gen...
Fangzhou Inc. has announced the launch of Kyinsu®, the world's first once-weekly basal insulin/GLP-1 RA combination ...
South Korea-based Samsung Biologics has announced the launch of an all-cash public tender offer to acquire 100% of the f...
Galderma has announced the launch of Alastin – its premium regenerative skincare brand – across the JPAC reg...
Merck, a leading science and technology company, has opened a new €25 million BioReliance® testing facility at ...
Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distri...
AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy ...
India's Sai Parenterals has announced that its Australian subsidiary, Noumed Pharmaceuticals, has successfully renewed i...
How does CT fit into your overall regional expansion strategy, especially in emerging markets like India and Southeast A...
Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treat...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based Shimadzu Corporation has completed the acquisition of all shares of Glass HoldCo s.r.o., which indirectly ho...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
South Korea-based Samsung Bioepis has entered into a license agreement with Proteina Co. to collaborate on a government-...
Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsi...
Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
Hong Kong-based Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, has announced a strategi...
China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the offi...
